For Cancer Therapy Suppliers Serving Switzerland

NANOLEK is a modern, fast-growing Russian biopharmaceutical company, specializing in the production of import-substituting and innovative drugs. Our high-tech full-cycle production facilities fully comply with GMP and ISO standards. Our portfolio ...

Hitachi America, Ltd. was established as a regional subsidiary and the first manufacturing facility was completed in 1977. Now Hitachi has more than 24,700 employees among its 72 Group companies in the U.S. and 19 R&D labs operating in 37 states, ...

Blue Earth Diagnostics is an established molecular imaging company on a growth trajectory to provide innovative, well differentiated diagnostics solutions, informing patients and driving future therapies in cancer. Formed in 2014, Blue Earth ...

Veru is a biotechnology company focused on developing novel medicines for COVID-19, additional ARDS-related diseases, and for breast and prostate cancers. Veru is a Wisconsin corporation and is the successor to The Wisconsin Pharmacal Company, Inc. ...

Enterome is pioneering the discovery and development of novel pharmaceuticals based on its unrivalled understanding of the interaction between the gut microbiome and the immune system – the Microbiome-Immunoinflammation Axis. Enterome is using this ...

We believe in the patient above all – for their comfort and for their future. We are shaping the future of healthcare through innovative technologies that create life-changing experiences for patients all over the world. Our regulatory cleared ...

ImCare Biotech is a biotechnology company founded in 2011 by Dr. Xuanyong Lu, formerly a professor at Drexel University’s Institute for Biotechnology and Virology. The company’s primary products in development are innovative diagnostic biomarkers as ...

We are dedicated to one thing: improving outcomes for cancer patients. That’s why we focus on developing innovative diagnostic solutions that give patients and doctors the information they need—all from a simple blood test, known as a liquid biopsy. ...

Metaclipse Therapeutics Corporation is developing novel personalized vaccine immunotherapies for cancer. MembrexTM, a proprietary platform approach tailored to each patient and their specific tumor, consists of ‘membrane vesicles’ prepared from a ...

VIDAR Systems Corporation is a publicly held optical imaging technology manufacturing company, specializing in medical and non-destructive testing (NDT) imaging markets. VIDAR is owned by 3D Systems, a leading global provider of 3D content-to-print ...

Neutron Therapeutics is a medical equipment company founded in November 2015. We are working to bring Boron Neutron Capture Therapy (BNCT) out of the realm of medical research and transform it into a widely available first-line cancer therapy. We ...

AVM Biotechnology is developing and advancing AVM0703, a proprietary formulation of concentrated dexamethasone. This formulation permits the very high dosing necessary to activate the release and trigger the production of the body’s supercharged ...

Sumitomo Pharma Oncology, Inc. is a developer of novel cancer therapeutics based in the U.S. and a wholly owned subsidiary of Sumitomo Pharma Co., Ltd. This U.S. entity, together with the oncology research and development teams in Japan, Cancer ...

IceCure Medical is an Israeli medical device company founded in 2006 to advance treatment of cancerous tumors. IceCure’s core technology is based on cryoablation, using freezing temperature (liquid nitrogen) to destroy tumors safely, quickly, and ...

VetStem Biopharma has endeavored to improve the lives of animals through regenerative medicine. As the first company in the United States to provide an adipose-derived stem cell service to veterinarians for their patients, VetStem pioneered the use ...

At LAVA, we are focused on applying our expertise in gamma-delta T cell engagers. We are building a pipeline of gamma-delta bsTCEs that have applications in both solid and hematologic malignancies. Our lead program, LAVA-051, targets the tumor ...

Virica was founded in 2018 based on a decade of research in the laboratory of Dr. Jean-Simon Diallo at the Ottawa Hospital Research Institute. Dr. Diallo was investigating novel oncolytic viral therapies (OVTs) and recognized the need for VSEs to ...

We are a specialized pharmaceutical company engaged in the research, development, manufacture and marketing of pharmaceutical products. Our operations encompass the marketing of both our own and licensed products and the provision of services, such ...

Exosome Diagnostics, Inc. is commercializing minimally invasive molecular diagnostics in blood and urine to enable doctors to select optimal therapies for cancer and other diseases. Exosomes are lipid bilayer covered microvesicles shed by solid ...

Burning Rock Biotech Limited (NASDAQ: BNR), whose mission is to Guard Life via Science, focuses on the application of next generation sequencing (NGS) technology in the field of precision oncology. Its business consists of i) NGS-based therapy ...